Nice chart w/JAKs/TYKs by drug and by cytokine pathways In reality there is a fair bit of crossover and "selectives" aren't nearly as selective as this implies Helpful to add deucravacitinib to the list! Looking forward to upcoming plenary #RheumNow #ACR22 #YearInReview https://t.co/MERzpvrFB9